Photodynamic inactivation strategies for maximizing antifungal effect against Sporothrix spp. and Candida albicans in an in vitro investigation

Amanda Regina Rocha,Natalia Mayumi Inada,Ana Paula da Silva,Vanderlei Salvador Bagnato,Hilde Harb Buzzá

DOI: https://doi.org/10.1371/journal.pntd.0012637

2024-11-13

PLoS Neglected Tropical Diseases

Abstract:Sporotrichosis is a zoonotic disease caused by the dimorphic fungus Sporothrix spp., leading to skin lesions that can, in some cases, progress and result in the death of infected individuals. Candida albicans is another fungus involved in several skin, oral, and vaginal mucosal infections. Fungal diseases are concerning due to increasing incidence and the limited variety of antifungal classes available for treatment. Furthermore, antifungal medications can cause various side effects, exacerbated by their prolonged use during infection treatment. There is a need to explore alternatives to conventional drugs that are effective, fast, and safe in combating sporotrichosis. This study aimed to achieve in vitro elimination of the fungi Sporothrix brasiliensis and Sporothrix schenckii through Photodynamic Inactivation (PDI), using curcumin as a photosensitizer and in combination with antifungal agents used in the treatment of sporotrichosis. Yeasts of Candida albicans , Sporothrix brasiliensis , and Sporothrix schenckii were subjected to Photodynamic Inactivation (PDI) using light at a wavelength of 450 ± 10 nm, irradiance of 35 mW/cm 2 , delivering a fluence of 31.5 J/cm 2 , with curcumin as the photosensitizer at doses ranging from 0.75 to 150 μg/mL. After determining the Minimum Inhibitory Concentration (MIC) values of the antifungal drugs itraconazole, ketoconazole, and potassium iodide, sub-MIC doses of these antifungals were combined with sub-MIC doses of curcumin in a new PDI session. Photodynamic inactivation is a promising technique in the treatment of sporotrichosis, as well as its combination with antifungals. The combination of curcumin in concentrations ranging from 0.75 g/mL a 7.5 g/mL with sub-MIC concentrations of itraconazole, ketoconazole, and potassium iodide was able to completely inactivate the fungi C . albicans , S . brasiliensis and S . schenckii , indicating that PDI may increase the effectiveness of antifungals. However, further studies are needed to establish protocols for future clinical applications. Fungal infections, notably sporotrichosis caused by Sporothrix spp., pose increasing challenges due to their infectious nature and limited treatment options. These infections are particularly concerning in immunocompromised individuals, resembling Candida albicans in their severity and potential for fatal outcomes. Treatment typically relies on oral antifungals, which are often difficult to administer effectively. Photodynamic Inactivation (PDI) emerges as a promising approach to enhance antifungal therapy. PDI combines a photosensitizing agent with specific wavelengths of light, generating reactive oxygen species that effectively target and eliminate microbial cells. In this study, we investigated PDI in conjunction with subinhibitory concentrations of curcumin and antifungal drugs (itraconazole, ketoconazole, potassium iodide) against Candida albicans , Sporothrix brasiliensis , and Sporothrix schenckii . Our results demonstrated that even at curcumin levels below inhibitory thresholds and antifungal concentrations as low as half the Minimum Inhibitory Concentration (MIC), PDI successfully eradicated these pathogens. This synergistic approach not only highlights PDI's efficacy as a precursor to antifungal treatment but also suggests potential benefits in reducing drug concentrations and associated side effects. Overall, this study underscores PDI's role as a potent adjunct therapy in combatting fungal infections, offering a promising strategy to improve treatment outcomes and manage infections caused by these challenging fungi.

tropical medicine,parasitology